Aristotle Atlantic Partners, LLC Buys Merck Inc, Exxon Mobil Corp, Union Pacific Corp, Sells Shire PLC, Ciena Corp, Oracle Corp

• New Purchases: UNP, AMT, GILD, TECH, COO, GPN, BMRN, IFF, SAGE, SUPN,
• Added Positions: MRK, XOM, MUR, CELG, ROP, TMO, JPM, AME, PCH, BA,
• Sold Out: SHPG, CIEN, ORCL, EVHC, CASY, BMY, ALB, GE,

For the details of Aristotle Atlantic Partners, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Aristotle+Atlantic+Partners%2C+LLC

1. Merck & Co Inc (MRK) - 695,010 shares, 14.63% of the total portfolio. Shares added by 14083.88%
2. Exxon Mobil Corp (XOM) - 329,696 shares, 9.46% of the total portfolio. Shares added by 554.52%
3. Union Pacific Corp (UNP) - 160,000 shares, 7.86% of the total portfolio. New Position
4. Murphy Oil Corp (MUR) - 548,637 shares, 6.42% of the total portfolio. Shares added by 2027.98%
5. Celgene Corp (CELG) - 176,392 shares, 4.86% of the total portfolio. Shares added by 2650.97%

Aristotle Atlantic Partners, LLC initiated holding in Union Pacific Corp. The purchase prices were between $130.02 and $147.02, with an estimated average price of $139.34. The stock is now traded at around $148.98. The impact to a portfolio due to this purchase was 7.86%. The holding were 160,000 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC initiated holding in American Tower Corp. The purchase prices were between $135.1 and $144.26, with an estimated average price of $138.95. The stock is now traded at around $149.54. The impact to a portfolio due to this purchase was 2%. The holding were 40,000 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC initiated holding in Gilead Sciences Inc. The purchase prices were between $64.88 and $75.68, with an estimated average price of $70.67. The stock is now traded at around $74.84. The impact to a portfolio due to this purchase was 1.53%. The holding were 62,500 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC initiated holding in Bio-Techne Corp. The purchase prices were between $144.9 and $165.58, with an estimated average price of $152.77. The stock is now traded at around $179.98. The impact to a portfolio due to this purchase was 1.39%. The holding were 27,110 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC initiated holding in The Cooper Companies Inc. The purchase prices were between $217.98 and $237.23, with an estimated average price of $228.53. The stock is now traded at around $253.15. The impact to a portfolio due to this purchase was 1.31%. The holding were 16,000 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC initiated holding in Global Payments Inc. The purchase prices were between $108.48 and $118.48, with an estimated average price of $112.99. The stock is now traded at around $116.92. The impact to a portfolio due to this purchase was 1.11%. The holding were 28,750 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC added to a holding in Merck & Co Inc by 14083.88%. The purchase prices were between $53.27 and $62.59, with an estimated average price of $59.12. The stock is now traded at around $67.37. The impact to a portfolio due to this purchase was 14.53%. The holding were 695,010 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC added to a holding in Exxon Mobil Corp by 554.52%. The purchase prices were between $73.22 and $83.6, with an estimated average price of $79.65. The stock is now traded at around $76.94. The impact to a portfolio due to this purchase was 8.01%. The holding were 329,696 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC added to a holding in Murphy Oil Corp by 2027.98%. The purchase prices were between $25.14 and $35.07, with an estimated average price of $30.85. The stock is now traded at around $29.89. The impact to a portfolio due to this purchase was 6.12%. The holding were 548,637 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC added to a holding in Celgene Corp by 2650.97%. The purchase prices were between $74.69 and $92.08, with an estimated average price of $83.1. The stock is now traded at around $89.27. The impact to a portfolio due to this purchase was 4.68%. The holding were 176,392 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC added to a holding in Roper Technologies Inc by 1311.34%. The purchase prices were between $262.64 and $286.33, with an estimated average price of $275.86. The stock is now traded at around $293.48. The impact to a portfolio due to this purchase was 3.98%. The holding were 44,697 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC added to a holding in Thermo Fisher Scientific Inc by 1204.43%. The purchase prices were between $203.14 and $219.53, with an estimated average price of $212.33. The stock is now traded at around $229.00. The impact to a portfolio due to this purchase was 3.54%. The holding were 53,260 shares as of 2018-06-30.

Aristotle Atlantic Partners, LLC sold out a holding in Shire PLC. The sale prices were between $148.46 and $173.13, with an estimated average price of $161.32.

Aristotle Atlantic Partners, LLC sold out a holding in Ciena Corp. The sale prices were between $23.41 and $26.88, with an estimated average price of $25.43.

Aristotle Atlantic Partners, LLC sold out a holding in Oracle Corp. The sale prices were between $42.82 and $48.45, with an estimated average price of $46.06.

Aristotle Atlantic Partners, LLC sold out a holding in Envision Healthcare Corp. The sale prices were between $35.83 and $44.78, with an estimated average price of $41.05.

Aristotle Atlantic Partners, LLC sold out a holding in Casey's General Stores Inc. The sale prices were between $96.17 and $109.58, with an estimated average price of $101.04.

Aristotle Atlantic Partners, LLC sold out a holding in Bristol-Myers Squibb Company. The sale prices were between $50.53 and $62.98, with an estimated average price of $54.03.